Timing of Postpartum Depressive Symptoms.
Journal
Preventing chronic disease
ISSN: 1545-1151
Titre abrégé: Prev Chronic Dis
Pays: United States
ID NLM: 101205018
Informations de publication
Date de publication:
09 Nov 2023
09 Nov 2023
Historique:
medline:
13
11
2023
pubmed:
9
11
2023
entrez:
9
11
2023
Statut:
epublish
Résumé
Postpartum depression is a serious public health problem that can adversely impact mother-child interactions. Few studies have examined depressive symptoms in the later (9-10 months) postpartum period. We analyzed data from the 2019 Pregnancy Risk Assessment Monitoring System (PRAMS) linked with data from a telephone follow-up survey administered to PRAMS respondents 9 to 10 months postpartum in 7 states (N = 1,954). We estimated the prevalence of postpartum depressive symptoms (PDS) at 9 to 10 months overall and by sociodemographic characteristics, prior depression (before or during pregnancy), PDS at 2 to 6 months, and other mental health characteristics. We used unadjusted prevalence ratios (PRs) to examine associations between those characteristics and PDS at 9 to 10 months. We also examined prevalence and associations with PDS at both time periods. Prevalence of PDS at 9 to 10 months was 7.2%. Of those with PDS at 9 to 10 months, 57.4% had not reported depressive symptoms at 2 to 6 months. Prevalence of PDS at 9 to 10 months was associated with having Medicaid insurance postpartum (PR = 2.34; P = .001), prior depression (PR = 4.03; P <.001), and current postpartum anxiety (PR = 3.58; P <.001). Prevalence of PDS at both time periods was 3.1%. Of those with PDS at both time periods, 68.5% had prior depression. Nearly 3 in 5 women with PDS at 9 to 10 months did not report PDS at 2 to 6 months. Screening for depression throughout the first postpartum year can identify women who are not symptomatic early in the postpartum period but later develop symptoms.
Identifiants
pubmed: 37943725
doi: 10.5888/pcd20.230107
pii: E103
pmc: PMC10684283
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E103Références
Womens Health (Lond). 2019 Jan-Dec;15:1745506519844044
pubmed: 31035856
Am J Public Health. 2018 Oct;108(10):1305-1313
pubmed: 30138070
MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):575-581
pubmed: 32407302
Health Aff (Millwood). 2021 Oct;40(10):1551-1559
pubmed: 34606354
MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):153-158
pubmed: 28207685
Ann Epidemiol. 2022 Apr;68:9-15
pubmed: 34974107
Obstet Gynecol. 2018 May;131(5):e140-e150
pubmed: 29683911
J Affect Disord. 2022 Oct 15;315:213-223
pubmed: 35803394
Ann Fam Med. 2009 Jan-Feb;7(1):63-70
pubmed: 19139451
Health Aff (Millwood). 2021 Oct;40(10):1605-1611
pubmed: 34606358
JAMA Psychiatry. 2021 Jul 1;78(7):778-787
pubmed: 33881474
Pediatrics. 2020 Nov;146(5):
pubmed: 33109744
J Am Board Fam Med. 2014 Jan-Feb;27(1):87-96
pubmed: 24390890
J Affect Disord. 2016 Jul 01;198:142-7
pubmed: 27016657
Am J Epidemiol. 2009 Jan 1;169(1):24-32
pubmed: 19001135
Obstet Gynecol. 2023 Jun 1;141(6):1232-1261
pubmed: 37486660
J Womens Health (Larchmt). 2019 Aug;28(8):1068-1076
pubmed: 31298606
Epidemiol Psychiatr Sci. 2020 Aug 12;29:e153
pubmed: 32782057
MMWR Morb Mortal Wkly Rep. 2021 Oct 08;70(40):1427-1432
pubmed: 34618798
JAMA. 2016 Jan 26;315(4):380-7
pubmed: 26813211
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Acta Psychiatr Scand. 2007 Sep;116(3):195-200
pubmed: 17655561
JAMA Psychiatry. 2013 May;70(5):490-8
pubmed: 23487258
Matern Child Health J. 2015 Apr;19(4):877-88
pubmed: 25081239
Pediatrics. 2019 Jan;143(1):
pubmed: 30559118
JAMA. 2020 Jun 09;323(22):2301-2309
pubmed: 32515821
J Psychiatr Res. 2018 Sep;104:235-248
pubmed: 30114665
J Womens Health (Larchmt). 2016 Nov;25(11):1112-1121
pubmed: 27310295